Nexthera Capital as of Dec. 31, 2016
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 39 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Shire | 13.0 | $22M | 130k | 170.38 | |
Novartis (NVS) | 8.4 | $14M | 198k | 72.84 | |
Celgene Corporation | 8.3 | $14M | 122k | 115.75 | |
Alexion Pharmaceuticals | 7.2 | $12M | 100k | 122.35 | |
Pfizer (PFE) | 6.1 | $10M | 318k | 32.48 | |
AstraZeneca (AZN) | 4.8 | $8.2M | 300k | 27.32 | |
Horizon Pharma | 4.7 | $8.1M | 500k | 16.18 | |
Astrazeneca Plc option | 4.0 | $6.8M | 250k | 27.32 | |
Tesaro | 3.9 | $6.7M | 50k | 134.48 | |
Kite Pharma | 3.9 | $6.7M | 150k | 44.84 | |
Alnylam Pharmaceuticals (ALNY) | 3.6 | $6.2M | 165k | 37.44 | |
Minerva Neurosciences | 3.4 | $5.8M | 493k | 11.75 | |
Neurocrine Biosciences (NBIX) | 2.7 | $4.6M | 120k | 38.70 | |
Acceleron Pharma | 2.7 | $4.5M | 178k | 25.52 | |
Insmed (INSM) | 2.5 | $4.3M | 322k | 13.23 | |
Eiger Biopharmaceuticals | 1.8 | $3.1M | 264k | 11.65 | |
Abeona Therapeutics | 1.6 | $2.8M | 569k | 4.85 | |
Adamas Pharmaceuticals | 1.5 | $2.6M | 152k | 16.90 | |
Fibrogen (FGEN) | 1.5 | $2.5M | 116k | 21.40 | |
Trevena | 1.4 | $2.3M | 399k | 5.88 | |
Cara Therapeutics (CARA) | 1.4 | $2.3M | 250k | 9.29 | |
Newlink Genetics | 1.2 | $2.1M | 200k | 10.28 | |
Ascendis Pharma A S (ASND) | 1.2 | $2.0M | 100k | 20.24 | |
Zogenix | 1.1 | $1.8M | 150k | 12.15 | |
Concert Pharmaceuticals I equity | 1.0 | $1.7M | 168k | 10.29 | |
Sangamo Biosciences (SGMO) | 0.9 | $1.5M | 503k | 3.05 | |
Paratek Pharmaceuticals | 0.9 | $1.5M | 100k | 15.40 | |
Advaxis | 0.8 | $1.4M | 200k | 7.16 | |
Axovant Sciences Ltd call | 0.7 | $1.2M | 100k | 12.42 | |
Immune Design | 0.6 | $1.1M | 199k | 5.50 | |
Clearside Biomedical (CLSD) | 0.6 | $1.1M | 121k | 8.94 | |
Redhill Biopharma Ltd cmn | 0.6 | $994k | 95k | 10.46 | |
Global Blood Therapeutics In | 0.5 | $867k | 60k | 14.45 | |
Intec Pharma | 0.5 | $791k | 139k | 5.70 | |
Vistagen Therapeutics | 0.3 | $515k | 138k | 3.73 | |
Amicus Therapeutics | 0.3 | $497k | 100k | 4.97 | |
Verastem | 0.2 | $376k | 336k | 1.12 | |
Vascular Biogenics | 0.1 | $162k | 33k | 4.86 | |
Tracon Pharmaceuticals | 0.0 | $62k | 13k | 4.88 |